LINDSAY JEBO: Open Payments
NPI 1497001739 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 63 payments from 12 companies in 2025. Trend: 2023 $394 · 2024 $681 · 2025 $1,281
Food & beverage: $1,231Education: $50
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $443 |
| Insmed, Inc. | 19 | $160 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Astellas Pharma US Inc | 4 | $121 |
| Amgen Inc. | 4 | $115 |
| Grifols USA, LLC | 4 | $94 |
| Verona Pharma, Inc. | 2 | $54 |
| 3B Medical, Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $36 |
| Philips North America LLC | 1 | $28 |
Products named: NUCALA, Arikayce, TEZSPIRE, Cresemba, Prolastin-C Liquid, TRELEGY ELLIPTA, AIRSUPRA, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
